Latest in FAIM
iiiiiiiii
September 1, 2022
at September 1, 2022Published by AI History
1969 was a flourishing time for AI, with new conference publications and dissertations...
Do you like it?
September 1, 2022
at September 1, 2022Published by Editor’s Pick
Genomic insights for infectious diseases with a non-invasive Test to help make rapid treatment decisions.
Do you like it?
September 1, 2022
at September 1, 2022Published by Wearable Devices
Relay live and detailed vital data to their healthcare providers safely and instantaneously using a simple non-invasive wireless device...
Do you like it?
September 1, 2022
at September 1, 2022Published by FDA Updates
Cognoa aims to rule out or diagnose ASD.
Olympus's endoscope spots suspicious lesions and polyps.
The BioSticker prevent illness exacerbation...
Do you like it?
September 1, 2022
September 1, 2022
at September 1, 2022Published by Leaders
Unraveling the brain's mysteries to understand more about diseases is the key point behind Theodoros Zanos' years in neuroscience research and machine learning...
Do you like it?
September 1, 2022
at September 1, 2022Published by Journal Club
Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning...
Do you like it?
September 1, 2022
at September 1, 2022Published by AI Technical
AI is developing rapidly as scientists find more ways to have it mimic natural processes, like using Darwin's theory of evolution...
Do you like it?
August 1, 2022
at August 1, 2022Published by FDA Updates
Bedside G6PD Deficiency Testing to improve hyperbilirubinemia management, painless blood sampling with microneedles...
Do you like it?
Expert Interview
Dr. Sameer Mehta
Editor-In Chief & Founder
Sameer Mehta, MD, FACC, MBA, is a U.S. interventional cardiologist
Journal Club
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens
JAMA Network Open – Oncology – May 13, 2020
SIGN UP FOR OUR NEWSLETTER
Join our subscribers list to get the latest news and updates directly in your inbox.